Zoetis Inc. (ZTS) Position Reduced by Ifrah Financial Services Inc.

Ifrah Financial Services Inc. decreased its position in Zoetis Inc. (NYSE:ZTS) by 18.0% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 9,368 shares of the company’s stock after selling 2,060 shares during the period. Ifrah Financial Services Inc.’s holdings in Zoetis were worth $597,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of ZTS. Capital One National Association acquired a new position in Zoetis in the 2nd quarter worth approximately $276,000. NN Investment Partners Holdings N.V. boosted its stake in Zoetis by 22.4% in the 2nd quarter. NN Investment Partners Holdings N.V. now owns 55,484 shares of the company’s stock worth $3,461,000 after purchasing an additional 10,171 shares during the period. Creative Planning boosted its stake in Zoetis by 25.3% in the 2nd quarter. Creative Planning now owns 9,877 shares of the company’s stock worth $616,000 after purchasing an additional 1,996 shares during the period. Mn Services Vermogensbeheer B.V. boosted its stake in Zoetis by 546.3% in the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 80,870 shares of the company’s stock worth $5,045,000 after purchasing an additional 68,358 shares during the period. Finally, Eqis Capital Management Inc. acquired a new position in Zoetis in the 2nd quarter worth approximately $352,000. 92.44% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This story was first posted by Transcript Daily and is the property of of Transcript Daily. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://transcriptdaily.com/2017/11/14/zoetis-inc-zts-position-reduced-by-ifrah-financial-services-inc.html.

A number of equities research analysts have issued reports on ZTS shares. Cowen and Company set a $70.00 target price on shares of Zoetis and gave the company a “buy” rating in a research note on Monday, July 17th. Cantor Fitzgerald set a $75.00 target price on shares of Zoetis and gave the company a “buy” rating in a research note on Monday, August 14th. Stifel Nicolaus reissued a “buy” rating and set a $65.00 target price on shares of Zoetis in a research note on Friday, July 21st. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and set a $62.00 target price on shares of Zoetis in a research note on Monday, August 7th. Finally, BidaskClub raised shares of Zoetis from a “hold” rating to a “buy” rating in a research note on Tuesday, November 7th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company. Zoetis currently has an average rating of “Buy” and a consensus target price of $67.06.

Zoetis Inc. (ZTS) traded down $0.25 during trading on Tuesday, hitting $68.88. 2,747,400 shares of the stock were exchanged, compared to its average volume of 2,817,065. The company has a market cap of $33,686.24, a P/E ratio of 31.71, a P/E/G ratio of 2.02 and a beta of 1.02. The company has a quick ratio of 1.95, a current ratio of 2.80 and a debt-to-equity ratio of 2.45. Zoetis Inc. has a fifty-two week low of $48.24 and a fifty-two week high of $70.48.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share for the quarter, beating analysts’ consensus estimates of $0.63 by $0.02. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.32 billion. Zoetis had a net margin of 18.29% and a return on equity of 62.39%. Zoetis’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.52 EPS. equities research analysts anticipate that Zoetis Inc. will post 2.36 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be issued a dividend of $0.105 per share. The ex-dividend date of this dividend is Wednesday, November 8th. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.61%. Zoetis’s dividend payout ratio is currently 22.11%.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply